| Preview | Issue Date | Title / Name | Author(s) | Type |
| 2019 | A Victorian clinician-based survey on current practices for breast cancer staging in pregnancy | Herbison, Harriet; Miller, Abigail; Hart, Christopher D.; Hayes, Theresa M.; Shnier, Darryl, et al | Conference Paper | |
| 2022 | Achieving equitable access to cancer care and clinical trials in regional Australia: A networked approach to expand capacity and implement COSA teletrials model | Underhill, Craig; Long, Donna; Collins, Ian M.; Brown, Stephen; Harris, Samuel, et al | Conference Paper | |
| 2020 | Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer | Loft, Matthew; Lok, Sheau Wen; De Boer, Richard H.; Malik, Laeeq; Greenberg, Sally, et al | Journal Article | |
| Jan-2023 | Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer | Loft, Matthew; Lok, Sheau Wen; De Boer, Richard; Malik, Laeeq; Greenberg, Sally, et al | Journal Article | |
| 2022 | CDK4/6 Inhibitors (CKD4/6i) in advanced hormone-receptor-positive (HR+) HER2-negative (HER2-) breast cancer: Prescribing practices and outcomes in a real-world, Australian cohort | Javaid, Anadil; Lok, Sheau Wen; Wong, Vanessa; Baron-Hay, Sally; Boyle, Fran, et al | Conference Paper | |
| 10-Nov-2023 | A combined analysis of two randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma | Gately, Lucy; Mesia, Carlos; Sepulveda, Juan; del Barco, Sonia; Pineda, Estela, et al | Conference Paper | |
| Nov-2020 | Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer | Collins, Ian M.; Kanjanapan, Yada; Wen Lok, Sheau; Gibbs, Peter; De Boer, Richard, et al | Journal Article | |
| 2021 | Improving regional access to clinical trials and implementation of COSA teletrials model by a networked approach: Regional Trials Network Victoria | Underhill, Craig R.; Long, Donna; Collins, Ian M.; Brown, Stephen; Harris, Samuel J., et al | Conference Paper | |
| 31-May-2023 | Real world evidence of systemic therapy in hormone receptor positive advanced breast cancer (HR+ ABC) in Australia: ARORA Registry. | Wen Lok, Sheau; Tung, Iris; Anton, Angelyn; Baron-Hay, Sally E.; De Boer, Richard H., et al | Conference Paper | |
| 2020 | Real world outcomes in elderly patients with HER2 positive advanced breast cancer | Evans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et al | Conference Paper | |
| 2021 | Real world outcomes in elderly women with HER2 positive advanced breast cancer | Evans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et al | Conference Paper | |
 | 2020 | Real World Outcomes in Elderly Women with HER2-Positive Advanced Breast Cancer | Evans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et al | Conference Paper | |
| 2020 | Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer | Conduit, C.; de Boer, R. H.; Lok, S.; Gibbs, Peter; Malik, Laeeq, et al | Journal Article | |
| 2021 | Real-world outcomes in patients with brain metastases secondary to HER2-positive breast cancer: An Australian multi-centre registry-based study | Tung, Iris; Moldovan, Cristina; Wong, Vanessa; De Boer, Richard; Gibbs, Peter, et al | Conference Paper | |
| Oct-2022 | Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study | Tung, Iris; Moldovan, Cristina; Wong, Vanessa; De Boer, Richard; Yeo, Belinda, et al | Journal Article | |
| 2020 | Real-world uptake of bone modifying agents in advanced breast cancer with bone metastases-Prospective data from a multi-site Australian registry | Wong, Vanessa; De Boer, Richard; Anton, Angelyn; Malik, Laeeq; Greenberg, Sally, et al | Conference Paper | |
| 2022 | Regional Victorian trials alliance: Linkages, Innovation, Special populations, Equity (ReViTALISE) project: Addressing disparity in regional populations | Long, Donna; Collins, Ian M.; Harris, Samuel; Torres, Javier; Faisal, Wasek, et al | Conference Paper | |
 | 21-Dec-2023 | Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial | Alexander, Marliese; Collins, Ian, M.; Abraham, Patrick; Underhill, Craig; Harris, Samuel, et al | Journal Article | |
| 2021 | Uptake of bone-modifying agents in patients with HER2+ metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registry | Wong, Vanessa; de Boer, Richard; Dunn, Catherine; Anton, Angelyn; Malik, Laeeq, et al | Journal Article | |
